Attached files

file filename
EX-3.2 - EIGHTH AMENDED AND RESTATED BYLAWS OF CME GROUP INC - CME GROUP INC.d359429dex32.htm
EX-10.1 - CME GROUP INC. AMENDED AND RESTATED OMNIBUS STOCK PLAN - CME GROUP INC.d359429dex101.htm
EX-10.2 - AMENDED AND RESTATED CME GROUP INC. EMPLOYEE STOCK PURCHASE PLAN - CME GROUP INC.d359429dex102.htm
EX-3.1 - FOURTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CME GROUP INC - CME GROUP INC.d359429dex31.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported)

May 23, 2012

 

 

CME GROUP INC.

(Exact Name of Registrant as Specified in Charter)

 

 

 

Delaware   001-31553   36-4459170

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File No.)

 

(IRS Employer

Identification No.)

 

20 South Wacker Drive

Chicago, Illinois

  60606
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code: (312) 930-1000

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 1.01. Entry into a Material Definitive Agreement.

At the 2012 CME Group Inc. (the “Company”) Annual Meeting of Shareholders held on May 23, 2012, (the “Annual Meeting”) shareholders approved proposals to adopt amendments to the Company’s Omnibus Stock Plan and Employee Stock Purchase Plan. The amendments to the Omnibus Stock Plan include an extension of the term of the plan to June 30, 2022, the addition of new performance metrics and an amendment to the change of control provisions to provide that performance-based awards granted following the amendment shall vest in the event of a change of control at the greater of (i) actual performance at the time of the change of control or (ii) the target level. The amendments to the Employee Stock Purchase Plan increased the number of available shares from 40,000 to 100,000 and extended the expiration date to June 30, 2022.

The foregoing description is qualified in its entirety by reference to the copy of the Amended and Restated Omnibus Stock Plan and the Amended and Restated Employee Stock Purchase Plan, which are filed as Exhibit 10.1 and Exhibit 10.2, respectively, to this Current Report on Form 8-K.

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

At the Annual Meeting, shareholders approved a proposal to adopt amendments (the “Amended Charter”) to the Company’s Third Amended and Restated Certificate of Incorporation to (i) phase out the classification of the Company’s Board of Directors as of its 2014 Annual Meeting, such that each director will be elected to a one-year term beginning with the Company’s 2014 Annual Meeting and (ii) remove certain obsolete provisions contained in the Third Amended and Restated Certificate of Incorporation. Upon shareholder approval of this proposal, conforming amendments (the “Amended Bylaws”) to the Company’s Seventh Amended and Restated Bylaws became effective as well.

The foregoing description is qualified in its entirety by reference to the copy of the Amended Charter and Amended Bylaws, which are filed as Exhibit 3.1 and Exhibit 3.2, respectively, to this Current Report on Form 8-K.

Item 5.07. Submission of Matters to a Vote of Security Holders.

At the close of business on March 28, 2012, the record date of the Annual Meeting, the Company had 66,465,050 shares of Class A and Class B common stock issued and outstanding. The holders of a total of 55,012,937 shares of Class A and Class B common stock were present at the Annual Meeting, either in person or by proxy, which total constituted approximately 83% of the issued and outstanding shares on the record date for the Annual Meeting.


The results of the proposals are as follows:

 

  1. The election of seven Equity Directors to serve until 2014 (elected by the Class A and Class B shareholders voting together as a single class):

 

Name

   Votes For      Votes Withheld  

Dennis H. Chookaszian

     30,203,602         16,598,361   

Larry G. Gerdes

     41,955,704         4,846,259   

Daniel R. Glickman

     45,347,670         1,454,293   

James E. Oliff

     45,484,554         1,317,409   

Edemir Pinto

     45,276,612         1,525,351   

Alex J. Pollock

     42,636,508         4,165,455   

William R. Shepard

     41,988,834         4,813,129   

There were a total of 8,210,974 broker non-votes in this proposal.

 

  2. The ratification of the appointment of Ernst & Young LLP as the Company’s independent public accounting firm for 2012 (ratified by the Class A and Class B shareholders voting together as a single class):

 

Votes For

   Votes Against      Abstentions  

50,623,354

     4,128,568         261,015   

 

  3. The approval, by advisory vote, of the compensation of the Company’s named executive officers (approved by the Class A and Class B shareholders voting together as a single class):

 

Votes For

   Votes Against      Abstentions  

45,024,998

     1,604,856         172,109   

There were a total of 8,210,974 broker non-votes in this proposal.

 

  4. Approval of the Fourth Amended and Restated Certificate of Incorporation to eliminate classification of the Company’s Board of Directors as of the 2014 Annual Meeting(approved by the Class A and Class B shareholders voting together as a single class):

 

Votes For

   Votes Against      Abstentions  

46,307,699

     342,342         151,922   

There were a total of 8,210,974 broker non-votes in this proposal.


  5. Approval of the Amended and Restated Omnibus Stock Plan (approved by the Class A and Class B shareholders voting together as a single class):

 

Votes For

   Votes Against      Abstentions  

43,703,392

     2,969,433         129,138   

There were a total of 8,210,974 broker non-votes in this proposal.

 

  6. Approval of the Amended and Restated Employee Stock Purchase Plan (approved by the Class A and Class B shareholders voting together as a single class):

 

Votes For

   Votes Against      Abstentions  

45,879,641

     797,990         124,332   

There were a total of 8,210,974 broker non-votes in this proposal.

 

  7. Shareholder Proposal Regarding Proxy Access (failed to receive sufficient support from the Class A and Class B shareholders voting together as a single class):

 

Votes For

   Votes Against      Abstentions  

17,699,882

     28,937,468         164,613   

There were a total of 8,210,974 broker non-votes in this proposal.

 

  8. The election of Class B Directors:

 

  a. The election of one Class B-1 Director to serve until 2014 from a slate of three nominees (elected by the Class B-1 shareholders):

 

Name

   Votes For      Votes Against      Abstentions  

Jeffrey M. Bernacchi

     157         46         114   

Gary T. Lark

     31         80         206   

Gerard M. Shannon

     106         61         150   

 

  b. The election of one Class B-2 Director to serve until 2014 from a slate of three nominees (elected by the Class B-2 shareholders):

 

Name

   Votes For      Votes Against      Abstentions  

Yra G. Harris

     72         95         221   

Patrick J. Mulchrone

     67         100         221   

David J. Wescott

     202         39         147   


  9. The election of Class B Nominating Committees:

 

  a. The election of five members of the Class B-1 Nominating Committee to serve until 2013 from a slate of ten nominees (elected by the Class B-1 shareholders):

 

Name

   Votes For      Votes Against      Abstentions  

William C. Bauman

     127         30         155   

Thomas A. Bentley

     122         38         152   

Michael J. Downs

     122         38         152   

Steven I. Freeman

     50         68         194   

Stephen F. French

     87         54         171   

John C. Garrity

     150         27         135   

Mark S. Kobilca

     58         53         201   

Brian J. Muno

     115         38         159   

Michael J. Small

     86         41         185   

Kenneth G. Zekich

     57         54         201   

 

  b. The election of five members of the Class B-3 Nominating Committee to serve until 2013 from a slate of ten nominees (elected by the Class B-3 shareholders) was deferred to June 13, 2012 at 12:00 p.m. at 20 South Wacker Drive, Chicago, Illinois.

Item 9.01. Financial Statements and Exhibits.

 

3.1    Fourth Amended and Restated Certificate of Incorporation of CME Group Inc.
3.2    Eighth Amended and Restated Bylaws of CME Group Inc.
10.1   

CME Group Inc. Amended and Restated Omnibus Stock Plan

(amended and restated as of May 23, 2012)

10.2    Amended and Restated CME Group Inc. Employee Stock Purchase Plan (amended and restated as of May 23, 2012)


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

   

CME Group Inc.

Registrant

Date: May 29, 2012     By:   /s/ Kathleen M. Cronin
    Name:   Kathleen M. Cronin
    Title:  

Senior Managing Director, General

Counsel and Corporate Secretary


Exhibit Index

 

3.1    Fourth Amended and Restated Certificate of Incorporation of CME Group Inc.
3.2    Eighth Amended and Restated Bylaws of CME Group Inc.
10.1   

CME Group Inc. Amended and Restated Omnibus Stock Plan

(amended and restated as of May 23, 2012)

10.2    Amended and Restated CME Group Inc. Employee Stock Purchase Plan (amended and restated as of May 23, 2012)